Recherche Images Maps Play YouTube Actualités Gmail Drive Plus »
Connexion
Les utilisateurs de lecteurs d'écran peuvent cliquer sur ce lien pour activer le mode d'accessibilité. Celui-ci propose les mêmes fonctionnalités principales, mais il est optimisé pour votre lecteur d'écran.

Brevets

  1. Recherche avancée dans les brevets
Numéro de publicationUS3185626 A
Type de publicationOctroi
Date de publication25 mai 1965
Date de dépôt6 mars 1963
Date de priorité6 mars 1963
Numéro de publicationUS 3185626 A, US 3185626A, US-A-3185626, US3185626 A, US3185626A
InventeursBaker Claude W
Cessionnaire d'origineSterling Drug Inc
Exporter la citationBiBTeX, EndNote, RefMan
Liens externes: USPTO, Cession USPTO, Espacenet
Tablet coating method
US 3185626 A
Résumé  disponible en
Images(2)
Previous page
Next page
Revendications  disponible en
Description  (Le texte OCR peut contenir des erreurs.)

United States Patent 3,185,626 TABLET CGATING METHOD Claude W. Baker, Albany, N.Y., assigner to Sterling Drug Inc, New York, N.Y., a corporation of Delaware No Drawing. Filed Mar. 6, 1963, Ser. No. 263,100

5 Claims. (Cl. 167--82) This invention relates to tablets and other individual dosage forms. More particularly the invention is concerned with an economical, time-saving process for sugar coating core tablets.

Tablet coating is an old art in which traditional methods have remained essentially unchanged although in recent years some steps have been made toward reducing the tedious and time-consuming operation. Thus, a tablet or compressed pellet is sized with a water repellent resin such as shellac or zein and the resultant tablet 0r pellet is then subcoated with several coats of a material such as gelatin or acacia along with subcoating powders designed for dusting the subcoats. The subcoating operation although time consuming and expensive has been considered necessary in order to round and shape the tablet preparatory to applying a sugar coating with or without added coloring. After further finishing and polishing there is obtained a pharmaceutically elegant tablet but the inordinate amount of time required in the application and drying of the numerous coats including subcoating, color coating and smoothing coat maks the production of such tablets quite expensive.

In comparatively recent times various film coating procedures have been introduced and these methods have materailly reduced the time required to prepare a finished tablet. However, the film coating procedures suffer from a number of disadvantages which in certain instances outweigh the time-saving advantages. For example, the filmforming materials being organic in nature require the use of organic solvents, e.g., alcohol, acetone, ether etc., which are flammable and toxic. It is therefore necessary to carry out the process in explosion-proof equipment with provision for adequate ventilation and exhaust.

Further complications to the well-known tabletting procedures are introduced when it is desired to color the tablet for purposes of distinctiveness or identification. For many years only dyes of the soluble type were used and this necessarily limited the number and range of colors that could be used. In recent times insoluble dyes or lakes have been incorporated into coloring compositions by the use of surfactants to maintain the dyes or lakes in suspension and more recently it has been found that the surfactant was unnecessary. These improvements materially reduced the operating time for coloring solids but the time-consuming subcoating of the tablets was still carried out.

According to the present invention core tablets, that is, tablets which may be sealed, sized or enteric coated but not rounded, are sugar coated in one-quarter to one-third the time required by any previously known method. Utilization of the compositions and process of the invention greatly reduces the operating time by eliminating completely subcoats and smoothing coats hitherto believed necessary.

Additionally, a color, either water-soluble or waterinsoluble, can be incorporated at any stage to give a stable, pharmaceutically elegant finished tablet for which the color is reproducible from batch to batch or operator to operator. There is no necessity for subcoating the rough core tablet or applying smoothing coats yet the finished tablet has stability upon aging, resistance to cracking during sudden temperature changes and a pleasing appearance 7O comparable with tablets made by conventional procedures.

Patented May 25, 1965 The compositions useful in the process of the invention are comprised of an adhesive aqueous suspending medium such as a gelatin solution or preferably a syrup solution and an opaque non-toxic, pharmaceutically acceptable water insoluble pigment as for example titanium dioxide, iron oxide, barium sulfate and calcium carbonate, and if desired a non-toxic dye of either the water-soluble or water-insoluble type.

The aqueous suspending medium is preferably a syrup solution, e.g., an aqueous sugar solution such as an aqueous solution of glucose, lactose, maltose or sucrose. The preferred syrup or sugar solution is a sucrose solution although other sugar derivatives such as mannitol and sorbitol can be used.

The compositions useful in carrying out the improved process can, if desired, contain coloring materials which are any of the non-toxic dyes, lakes and pigments which have been certified for use in the food, drug and cosmetic industries. For example, water-soluble dyes as illustrated by PD & C Yellow No. 5, water-insoluble dyes and lakes as illustrated by .D & C Green No. 5 and pigments as illustrated by yellow, brown, red and black iron oxides, titanium dioxide and barium sulfate are suitable as colorants.

The method of coating core tablets in accordance with the invention comprises forming the syrup or sugar solution in which is suspended the opacifying material by the use of suitable mixing equipment. The suspension is then added to core tablets in a rotating coating pan and the appropriate number of coats applied with air drying after each coat. At any stage colors of the type described above can be added if desired by adding the appropiate color to the syrup and applying the number of coats necessary to give the desired coloring.

The following examples will further illustrate the invention, without however limiting the latter thereto.

Example 1 Coating suspensions incorporating various dyes were prepared as follows:

(A) Grams FD & C Yellow No. 5 0.20

Titanium dioxide, N.F. 7.20

Sucrose (as 70% syrup) 360.00

PD 8.: C Blue No. 1 0.07

Titanium dioxide, N.F. 7.20

Sucrose (as 70% syrup) 360.00

PD & C Yellow No. 6 0.22

Titanium dioxide, N.F. 7.20

Sucrose (as 70% syrup) 360.00

FD & C Red No. 4 0.25

Titanium dioxide, N.F. 7.20

Sucrose (as 70% syrup) 360.00

Mapico Black 0.72

Titanium dioxide, N.F. 7.20

Sucrose (as 70% syrup)- 360.00

Mapico Black 0.36

Brown iron oxide 7.20

Sucrose (as 70% syrup) 360.00

The dyes and pigments were suspended in the syrup and thoroughly mixed. Each of the coloring compositions was added to sized unrounded placebo tablets in a rotating pan until the tablets were evenly covered. The result- Example 2 Grams Titanium dioxide, NF. 14.0 Sucrose (as 70% syrup) 800.0

The above suspension was applied to a run of sized, unrounded oxypertine tablets rotating in a coating pan. A total of 40 mg. per tablet of the coating composition Was applied in about two and one-half hours to give a white sugar coated tablet equal in quality to oxypertine tablets coated in the conventional in five hours.

Example 3 Kilograms Brown iron oxide 0.232

Vanillin 0.004 Sucrose (as 70% syrup) 9.200

A suspension of the above ingredients was applied to a run of size, unrounded pancreatin-containing digestant tablets sold under the trademark Doxegest rotating in a coating pan. Application of the coating composition required about two and one-half hours and the resultant brown tablet was comparable to subcoated Doxegest tablets and required about one-third the time.

Example 4 Grams Titanium dioxide, NF. 2.80 FD & C Yellow No. 5 .062

Sucrost (as 70% syrup) 250.00

A suspension of the above ingredients was applied to a run of sized, unrounded cold tablets containing phenylephrine sold under the trademark Neosynephrine, acetyl p-aminophenol and vitamin C rotating in a coating pan. A total of 125 mg. per tablet was applied in about two and one-half hours. The yellow tablet thus obtained was equal in quality to sized, unrounded cold tablets coated in the conventional manner in six hours.

I claim:

1. .A method of coating tablets which comprises repeatedly adding portions of an aqueous suspending medium containing a non-toxic pharmaceutically acceptable pigment to sized, unround tablets rotating in a coating pan.

2. The method of claim 1 in which the pigment is selected from the group consisting of titanium dioxide, calicum carbonate, barium sulfate and iron oxide.

3. The method of claim 1 in which the aqueous suspending medium is a syrup solution.

4. The method of claim 1 in which a member of the group consisting of water-soluble and water-insoluble dyes is incorporated in the aqueous suspending medium.

5. The method according to claim 1 in which the aqueous suspending medium comprises a sucrose solution containing titanium dioxide and a colorant, and

.drying the finished tablets.

References Cited by the Examiner UNITED STATES PATENTS 9/62 Ralf 16782 9/64 Jeffries 16782

Citations de brevets
Brevet cité Date de dépôt Date de publication Déposant Titre
US3054724 *12 mai 196018 sept. 1962Smith Kline French LabColoring discrete solids and compositions therefor
US3149038 *5 sept. 196115 sept. 1964Dow Chemical CoThin film coating for tablets and the like and method of coating
Référencé par
Brevet citant Date de dépôt Date de publication Déposant Titre
US3361631 *30 sept. 19632 janv. 1968Sandoz AgMethod of sugar coating pharmaceutical tablets
US3421920 *25 mai 196514 janv. 1969Ciba Geigy CorpTablet coating containing a linear poly-1,3-beta-glucoside
US4146653 *10 août 197727 mars 1979J. Pfrimmer & Co.Process of manufacturing dragees
US4421738 *18 mars 198220 déc. 1983Eisai Co., Ltd.Sugar-coated tablet containing fat-soluble pharmaceutical material
US4423086 *16 oct. 198027 déc. 1983Roquette FreresProcess for hard coating with sorbitol and products obtained thereby
US4693750 *21 févr. 198615 sept. 1987Meggle Milchindustrie Gmbh & Co. Kg.Direct tabletting agent
US4820524 *20 févr. 198711 avr. 1989Mcneilab, Inc.Gelatin coated caplets and process for making same
US4867983 *4 déc. 198719 sept. 1989Mcneilab, Inc.Method for double dipping gelating coated caplets
US4965089 *10 avr. 198923 oct. 1990Sauter Manufacturing Corp.Method and apparatus for the gelatin coating of caplets
US4966771 *5 mai 198830 oct. 1990Mcneilab, Inc.Gelatin coated caplets and process for making same
US4990358 *21 mars 19895 févr. 1991Mcneilab, Inc.Method for double dipping gelatin coated caplets
US5198227 *22 janv. 199030 mars 1993Mcneil-Ppc, Inc.Dual subcoated simulated capsule medicament
US5296233 *11 déc. 199222 mars 1994Mcneil-Ppc, Inc.Dual subcoated simulated capsule-like medicament
US5314537 *5 mai 198824 mai 1994Mcneilab, Inc.Gelatin coated caplets and process for making same
US5512314 *28 nov. 199430 avr. 1996Warner-Jenkinson CompanyDye compositions and methods for film coating tablets and the like
US5658589 *31 oct. 199119 août 1997Mcneil-Ppc, Inc.Subcoated simulated capsule-like medicament
US5770225 *5 juin 199523 juin 1998Mcneil-Ppc, Inc.Process of preparing a subcoated simulated capsule-like medicament
US5916592 *18 févr. 199729 juin 1999Mcneil-Ppc, Inc.Subcoated simulated capsule-like medicament
US6080426 *11 janv. 199627 juin 2000Warner-Lamberg CompanyProcess for encapsulation of caplets in a capsule and solid dosage forms obtainable by such process
US6113945 *26 févr. 19965 sept. 2000L. Perrigo CompanyMulti-colored medicament
US6120801 *15 avr. 199919 sept. 2000Mcneil-Ppc, Inc.Subcoated simulated capsule-like medicament
US62143803 sept. 199910 avr. 2001Mcneil-Ppc, Inc.Subcoated simulated capsule-like medicament
US62453505 avr. 199612 juin 2001Warner-Lambert CompanyProcess for encapsulation of caplets in a capsule and solid dosage forms obtainable by such process
US632602614 janv. 20004 déc. 2001Mcneil-Ppc, Inc.Subcoated simulated capsule-like medicament
US70872423 oct. 20018 août 2006Mcneil-Ppc, Inc.Subcoated simulated capsule-like medicament
US74047087 déc. 200429 juil. 2008Mcneil-Ppc, Inc.System and process for providing at least one opening in dosage forms
US741673821 mars 200326 août 2008Mcneil-Ppc, Inc.Modified release dosage form
US74296192 août 200230 sept. 2008Mcneil Consumer HealthcarePolyacrylic film forming compositions
US75308047 déc. 200412 mai 2009Mcneil-Ppc, Inc.System and process for providing at least one opening in dosage forms
US763549021 mars 200322 déc. 2009Mcneil-Ppc, Inc.Modified release dosage form
US778565027 juin 200731 août 2010Mcneil-Ppc, Inc.Method for dip coating dosage forms
US783802628 oct. 200323 nov. 2010Mcneil-Ppc, Inc.Burst-release polymer composition and dosage forms comprising the same
US787935413 janv. 20041 févr. 2011Mcneil-Ppc, Inc.Rapidly disintegrating gelatinous coated tablets
US795565229 nov. 20077 juin 2011Mcneil-Ppc, Inc.Enrobed core
US796812028 sept. 200228 juin 2011Mcneil-Ppc, Inc.Modified release dosage forms
US797262424 févr. 20095 juil. 2011Shun-Por LiMethod of manufacturing modified release dosage forms
US806702923 juil. 200429 nov. 2011Mcneil-Ppc, Inc.Rapidly disintegrating gelatinous coated tablets
US81143284 août 200414 févr. 2012Mcneil-Ppc, Inc.Method of coating a dosage form comprising a first medicant
US828295724 juin 20099 oct. 2012Mcneil-Ppc, Inc.Coated particles containing pharmaceutically active agents
US830911821 juin 200213 nov. 2012Mcneil-Ppc, Inc.Film forming compositions containing sucralose
US835739517 déc. 200822 janv. 2013Mcneil-Ppc, Inc.Manufacture of tablet
US83836323 sept. 200926 févr. 2013Mcneil-Ppc, Inc.Method for making cetirizine tablets
US839441520 nov. 200712 mars 2013Mcneil-Ppc, IncModified release analgesic suspensions
US854588728 sept. 20021 oct. 2013Mcneil-Ppc, Inc.Modified release dosage forms
US8652517 *22 sept. 200518 févr. 2014Sandoz GmbhCoating of tablet cores
US86731907 déc. 201118 mars 2014Mcneil-Ppc, Inc.Method for manufacturing dosage forms
US867335215 avr. 200518 mars 2014Mcneil-Ppc, Inc.Modified release dosage form
US872208917 févr. 200913 mai 2014Mcneil-Ppc, Inc.Dip coated compositions containing a starch having a high amylose content
US877171631 janv. 20138 juil. 2014Mcneil-Ppc, Inc.Modified release analgesic suspensions
US881529016 déc. 201026 août 2014Mcneil-Ppc, Inc.Rapidly disintegrating gelatinous coated tablets
US914943818 juil. 20146 oct. 2015Johnson & Johnson Consumer Inc.Rapidly disintegrating gelatinous coated tablets
US20020031546 *3 oct. 200114 mars 2002Parekh Kishor B.Subcoated simulated capsule-like medicament
US20030108607 *21 juin 200212 juin 2003Szymczak Christopher E.Film forming compositions containing sucralose
US20030219484 *21 mars 200327 nov. 2003Sowden Harry S.Immediate release dosage form comprising shell having openings therein
US20030232083 *21 mars 200318 déc. 2003David WynnModified release dosage form
US20030235616 *21 mars 200325 déc. 2003Sowden Harry S.Modified release dosage form
US20040022755 *2 août 20025 févr. 2004Satish KamathPolyacrylic film forming compositions
US20040213849 *28 sept. 200228 oct. 2004Sowden Harry S.Modified release dosage forms
US20050008696 *4 août 200413 janv. 2005Sowden Harry S.Systems, methods and apparatuses for manufacturing dosage forms
US20050019407 *28 sept. 200227 janv. 2005Sowden Harry S.Composite dosage forms
US20050152970 *13 janv. 200414 juil. 2005Rinker Roger A.Rapidly disintegrating gelatinous coated tablets
US20050266084 *28 sept. 20021 déc. 2005Shun-Por LiModified release dosage forms
US20060034917 *22 sept. 200516 févr. 2006Reinhard EntnerCoating of tablet cores
US20060062811 *21 sept. 200423 mars 2006Szymczak Christopher EMedicinal cooling emulsions
US20060118991 *7 déc. 20048 juin 2006Sowden Harry SSystem and process for providing at least one opening in dosage forms
US20060121145 *7 déc. 20048 juin 2006Sowden Harry SSystem and process for providing at least one opening in dosage forms
US20060233881 *15 avr. 200519 oct. 2006Sowden Harry SModified release dosage form
US20060233882 *15 avr. 200519 oct. 2006Sowden Harry SOsmotic dosage form
US20070128268 *7 déc. 20057 juin 2007Herwig JenneweinPharmaceutical compositions comprising an antibiotic
US20070231389 *27 mars 20074 oct. 2007Bunick Frank JNon-homogenous dosage form coatings
US20070259098 *27 juin 20078 nov. 2007Cynthia GulianMethod for dip coating dosage forms
US20080031927 *11 juil. 20077 févr. 2008Catani Steven JSolid oral dosage vitamin and mineral compositions
US20080069880 *29 nov. 200720 mars 2008Bunick Frank JEnrobed core
US20080075766 *25 sept. 200627 mars 2008Shun-Por LiMulti-core dosage form having transparent outer coating
US20080118571 *20 nov. 200722 mai 2008Der-Yang LeeModified release analgesic suspensions
US20080311201 *12 juin 200718 déc. 2008Lee Der-YangModified release solid or semi-solid dosage forms
US20080317677 *22 juin 200725 déc. 2008Szymczak Christopher ELaser Marked Dosage Forms
US20080317678 *20 juin 200825 déc. 2008Szymczak Christopher ELaser Marked Dosage Forms
US20090074866 *15 sept. 200819 mars 2009Jen-Chi ChenDip coated compositions containing copolymer of polyvinyl alcohol and polyethylene glycol and a gum
US20090092739 *15 déc. 20089 avr. 2009Cynthia GulianMethod of dip-coating dosage forms
US20090148523 *6 févr. 200911 juin 2009Sowden Harry SSystem and process for providing at least one opening in dosage forms
US20090155372 *24 févr. 200918 juin 2009Shun-Por LiMethod of manufacturing modified release dosage forms
US20090162435 *17 déc. 200825 juin 2009Bunick Frank JManufacture of tablet
US20090176755 *11 sept. 20089 juil. 2009Herwig JenneweinPharmaceutical compositions comprising an antibiotic
US20090208574 *17 févr. 200920 août 2009Jen-Chi ChenDip coated compositions containing a starch having a high amylose content
US20090324716 *24 juin 200931 déc. 2009Robert ShenCoated Particles Containing Pharmaceutically Active Agents
US20100062061 *3 sept. 200911 mars 2010Kenneth DayMethod For Making Cetirizine Tablets
US20110086098 *16 déc. 201014 avr. 2011Rinker Roger ARapidly disintegrating gelatinous coated tablets
US20110200537 *22 avr. 201118 août 2011Szymczak Christopher ELaser marked dosage forms
EP1602363A12 juin 20057 déc. 2005McNeil-PPC, Inc.Immediate release dosage form comprising shell having openings therein
EP2255795A121 mars 20031 déc. 2010McNeil-PPC, Inc.Immediate release dosage form comprising shell having openings therein
WO1981001100A1 *16 oct. 198030 avr. 1981Roquette FreresProcess for hard coating with sorbitol and products obtained thereby
WO2001037816A2 *21 nov. 200031 mai 2001Biochemie Gesellschaft M.B.H.Coating of tablet cores
WO2001037816A3 *21 nov. 200029 nov. 2001Biochemie GmbhCoating of tablet cores
WO2004028508A121 mars 20038 avr. 2004Mcneil-Ppc, Inc.Modified release dosage forms with two cores and an opening
Classifications
Classification aux États-Unis427/2.2, 424/479
Classification internationaleA61K9/28
Classification coopérativeA61K9/28
Classification européenneA61K9/28